Ectopic pregnancy is an abnormal gestation in which the fertilized ovum is implanted outside the uterine cavity and the ampulla region of fallopian tube is the most common site of implantation [
1]. In vitro fertilization and embryo transfer (IVF-ET) has been described as one of the major causes for the condition [
2]. The incidence of multiple pregnancy has also increased with the increased use of assisted reproductive technology (ART) and it complicates approximately 0.8 % of pregnancies following infertility treatment [
3]. Cervical pregnancy is a life-threatening condition accounting for less than 1 % of ectopic gestations ranging between 1:10
3 and 1:18 × 10
4 pregnancies [
4]. It generally presents with profuse and painless vaginal bleeding, so diagnosis based on ultrasound imaging should be done as early as possible in order to facilitate the management for controlling severe vaginal bleeding [
5,
6]. There are several case reports in the literature about the successful usage of methotrexate administration either intra-muscularly or intra-amniotically, ultrasound-guided injection of potassium chloride (KCl) into the cervical gestation sac or the combination of both methotrexate and KCl injections [
7], and uterine artery embolization (UAE) [
8]. In any of the cases, close follow-up is mandatory in order to ensure the efficacy of the applied therapeutics and may demand additional interventions such as dilatation and curettage, hysteroscopic resection, and even hysterectomy. Thus there is no consensus regarding the best therapeutic approach for cervical pregnancy. The incidence of heterotopic pregnancy is extremely low, and a review of available literature fails to find a specific protocol for the management of such a condition. It is well established that hysteroscopy can provide a direct view [
9], and uterine artery embolization can prevent heavy uterine bleeding. With this in mind, we have successfully carried out hysteroscopic removal of gestational products of a heterotopic pregnancy following uterine artery embolization. To the best of our knowledge, this is the first case report about such a management for heterotopic pregnancy after IVF-ET.